EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Portable Home‐Use Triglyceride Meter Demonstrates Good Agreement With Plasma Laboratory Measures During Pregnancies Complicated by Metabolic Disease

S S Farabi, L A Barbour, E Z Dunn, C Ingram, E Lopez, J Hinojosa, E Phillips, N Hirsch, K Rolloff, S Pierce, J E Friedman, T L Hernandez

Endocrinology, Diabetes & Metabolism · 2026-05 · 9 (3)

DOI: 10.1002/edm2.70237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 09.05.2026. Verfasst von S S Farabi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Barnes-Jewish College Goldfarb School of Nursing, Office of Nursing Research, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Triglycerides, Pregnancy Complications, Obesity, Metabolic Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Janssen Research and Development, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fasting and postprandial triglycerides (PPTG) in obese pregnancies may be stronger predictors of fetal overgrowth than glucose, making them a potential novel treatment target. Measurement of TG currently requires venipuncture in a laboratory, a barrier to collecting repeated measures to understand contributions to fetal growth. Our aim was to evaluate agreement between fingerstick capillary TG using an FDA‐approved point‐of‐care (POC) meter and venipuncture plasma TG (vTG) during fasting and controlled fed conditions within pregnant women.

Methods

Pregnant patients ( n = 35) with obesity alone (59%) or GDM (41%) (BMI 33 ± 4 kg/m 2 ) had fasting vTG and POC TG collected, within ≤ 5 min apart at 25 ± 9 weeks' gestation. A subset ( n = 23) had PPTG collected at 1‐ and 2‐h after a controlled breakfast test meal (35 ± 2 weeks). Two‐way mixed effects intraclass correlations (ICC) and Bland–Altman plots determined agreement. Paired t ‐tests were used to compare vTG and POC TG (mean ± SD).

Results

Sixty‐eight paired fasting TG and 52 paired 1‐ and 2‐h PPTG were collected. Fasting vTG were slightly lower than POC TG (181 ± 66 vs. 192 ± 81 mg/dL), as were 1‐h (225 ± 65 vs. 260 ± 76) and 2‐h PPTG (227 ± 70 vs. 249 ± 77; p < 0.05 all). The ICC for fasting TG was 0.86 [95% CI: 0.78, 0.91] and 0.84 [95% CI: 0.32, 0.94] for PPTG. The mean % difference (vTG minus POC TG) was −4.6% ± 17.8% for fasting TG and −12.0% ± 12.0% for PPTG. Discussion/Conclusion These data suggest good agreement between vTG and POC TG in fasting and PPTG during pregnancies complicated by obesity and GDM. Our findings support the novel approach to utilising a POC TG meter, similar to a glucometer, to conveniently discern the contribution of TG and their potential targets in optimising fetal growth in pregnant patients with obesity and GDM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriglyceridesPregnancy ComplicationsObesityMetabolic DiseasesHumansFemalePregnancyAdultFastingPoint-of-Care SystemsPostprandial PeriodRapid Diagnostic Tests

Stichwörter der Autor:innen

agreementpregnancytriglyceride meter

Substanzen

Triglycerides

Autor:innen und Institutionen

  • Barnes-Jewish College Goldfarb School of Nursing, Office of Nursing Research, St. Louis, Missouri, USA.
  • School of Public Health, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Division of Nutritional Science & Obesity Medicine, Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
  • Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • College of Nursing, University of Colorado. Anschutz Medical Campus, Aurora, Colorado, USA.

Förderung

  • NIDDK NIH HHS
  • Janssen Research and Development
  • NCATS NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Center for Advancing Translational Sciences

Zitieren

APA

Farabi, S. S., Barbour, L. A., Dunn, E. Z., Ingram, C., Lopez, E., Hinojosa, J., Phillips, E., Hirsch, N., Rolloff, K., Pierce, S., Friedman, J. E., & Hernandez, T. L. (2026). Portable Home‐Use Triglyceride Meter Demonstrates Good Agreement With Plasma Laboratory Measures During Pregnancies Complicated by Metabolic Disease. Endocrinology, Diabetes & Metabolism, 9(3). https://doi.org/10.1002/edm2.70237

Vancouver

Farabi SS, Barbour LA, Dunn EZ, Ingram C, Lopez E, Hinojosa J, et al. Portable Home‐Use Triglyceride Meter Demonstrates Good Agreement With Plasma Laboratory Measures During Pregnancies Complicated by Metabolic Disease. Endocrinology, Diabetes & Metabolism. 2026;9(3). doi:10.1002/edm2.70237

BibTeX
@article{Farabi2026,
  author = {Farabi, S S and Barbour, L A and Dunn, E Z and Ingram, C and Lopez, E and Hinojosa, J and Phillips, E and Hirsch, N and Rolloff, K and Pierce, S and Friedman, J E and Hernandez, T L},
  title = {Portable Home‐Use Triglyceride Meter Demonstrates Good Agreement With Plasma Laboratory Measures During Pregnancies Complicated by Metabolic Disease},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  volume = {9},
  number = {3},
  doi = {10.1002/edm2.70237}
}
Kostenlos starten →